NFSG
UTHR icon

Newbridge Financial Services Group’s United Therapeutics UTHR Stock Holding History

Newbridge Financial Services Group’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.42K Hold
10
– – ﹤0.01% 955
2026
Q1 		$5.93K Hold
10
– – ﹤0.01% 890
2025
Q4 		$4.87K Hold
10
– – ﹤0.01% 902
2025
Q3 		$4.21K Hold
10
– – ﹤0.01% 1050
2025
Q2 		$2.93K Buy
+10
New +$2.99K ﹤0.01% 1101
2025
Q1 		– Sell
-71
Closed -$25.1K – 1160
2024
Q4 		$25.1K Buy
+71
New +$26.1K 0.01% 554
2023
Q1 		– Sell
-5
Closed -$1.23K – 1481
2022
Q4 		$1.39K Buy
+5
New +$1.26K ﹤0.01% 1270

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Newbridge Financial Services Group's UTHR Position: Q2 2026 in Review

Newbridge Financial Services Group held its United Therapeutics (UTHR) position steady in Q2 2026 at 10 shares worth $5.42K. The position accounts for ﹤0.01% of the portfolio, ranked #955.

Newbridge Financial Services Group first reported a position in UTHR in Q4 2022 and has held it in 7 quarters since. The position peaked at $25.1K in Q4 2024. 874 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Newbridge Financial Services Group held 10 shares of United Therapeutics worth $5.42K as of Q2 2026.
  • Newbridge Financial Services Group left its United Therapeutics share count unchanged in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Newbridge Financial Services Group's portfolio in Q2 2026, its #955 holding.
  • Newbridge Financial Services Group first reported a position in United Therapeutics in Q4 2022 and has held it in 7 quarters since.
  • Newbridge Financial Services Group's United Therapeutics position peaked at $25.1K in Q4 2024.
  • 874 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Newbridge Financial Services Group's 13F filing for Q2 2026, filed 14 Aug 2026.